MAD2L2 and central nervous system cancer: To confirm how MAD2L2 affects glioma proliferation and stemness, we performed differential analysis and GSEA enrichment analysis on GBM samples from three cohorts: TCGA-GBM (Fig. 7A), CGGA325, and CGGA693 (Additional file 1: Figure S4A).